What type of study is this?

Platelet parameters as biomarkers for retinopathy of prematurity in preterm infants born before 30 weeks of gestation

View Full Paper

Ask AI

Bookmark

Authors

Assessment reveals platelet markers predict treatment needs for retinopathy of prematurity in preterm infants, suggesting early screening is vital.

42.8% of preterm infants treated for ROP showed significant association with platelet parameters at birth and DOL 28.
Logistic regression demonstrated the odds ratio for plateletcrit and platelet mass index below threshold values increased treatment likelihood.
ROC analysis identified specific cut-off values for platelet parameters linked to ROP treatment necessity.
Findings indicate platelet metrics may serve as vital indicators for early intervention in vulnerable preterm infants.

Maeda et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Assessment reveals platelet markers predict treatment needs for retinopathy of prematurity in preterm infants, suggesting early screening is vital.